Home » Business, Health & Medicine, Pharmaceuticals & Biotech, World » Global Cord Stem Cell Banking Market will be worth USD 6.3 billion by 2022 – New market reports by Data Bridge Market Research
“Global Cord Stem Cell Banking Market is expected to grow at 22.4% in the forecast period 2016 to 2022”
Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Global Cord Stem Cell Banking Market is expected to reach USD 6.3 billion by 2022, from USD 1.5 billion in 2015 growing at a CAGR of 22.4% during the forecast period of 2016 to 2022.

Global Cord Stem Cell Banking market has been segmented and analyzed on the basis of storage, services, product type, source, indication, and geography.

For Sample Report: http://databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market-trends-forecast-2022/

Based on product type, the market has been segmented into Cord Blood, Cord Blood & Cord Tissue.

On the basis of storage, the cord stem cell banking market is segmented into Public Banking and Private Banking.

On the basis of service type the market is segmented into Collection & Transportation, Processing, Analysis, and Storage.

 

To read more about the scope and findings of this report visit: http://databridgemarketresearch.com/cord-stem-cell-banking-market-usd-6-3/

On the basis of source the market is segmented into Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, and Menstrual Blood.

Based on indication the market is further segmented into Cerebral Palsy, Thalassemia, Leukemia, Diabetes, and Autism.

 

Based on geography, the market report covers data for 5 geographical regions namely North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of intra-uterine devices market for global, North America, Europe and Asia Pacific.

Key players operating in this market are players operating in this market are CBR Systems, Inc., Cordlife, CryoCell, Cryo-Save AG, Lifecell, Stemcyte, Viacord, Smart Cells International, Ltd., Cryoviva India and China Cord Blood Corporation among others.

To Browse Full Report and Pricing: http://databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market-trends-forecast-2022/

 

Table of Contents:

1. INTRODUCTION

    1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET

    1.2. MARKET SEGMENTATION & COVERAGE

          1.2.1. CURRENCY AND PRICING 

          1.2.2. LIMITATION

2. RESEARCH METHODOLOGY

    2.1. KEY TAKEAWAYS

    2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE

          2.2.1. MARKET CRACKDOWN APPROACH 

          2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

          2.2.3. DATA TRIANGULATION

          2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

          2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

          2.2.6. PORTER’S FIVE FORCES MATRIX

          2.2.7. PEST ANALYSIS

    2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT

    2.3. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

    4.1. OVERVIEW

    4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS

    4.3. MARKET OVERVIEW

          4.3.1. DRIVERS

                   4.3.1.1. EASY EXTRACTION METHODS

                   4.3.1.2. RISING NUMBER OF NEWBORNS

                   4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS

                   4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT

          4.3.2. RESTRAINTS

                   4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES

                   4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS

                   4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS

          4.3.3. OPPURTUNITIES 

                   4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE

                   4.3.2.2. CORD BLOOD BANKS COLLABORATIONS

                   4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPEMENT

          4.3.4. THREATS

    4.4. KEY MARKET FINDINGS

    4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. CORD STEM CELL BANKING MARKET, BY STORAGE TYPE

    5.1. OVERVIEW

    5.2. PUBLIC CORD STEM CELL BANKING

          5.2.1. MARKET VALUE, 2014 TO 2022

          5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022

          5.2.3. MARKET TRENDS AND FORECAST INSIGHTS

    5.3. PRIVATE CORD STEM CELL BANKING

          5.3.1. MARKET VALUE, 2014 TO 2022

          5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022

          5.3.3. MARKET TRENDS AND FORECAST INSIGHTS

    5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING

6. CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE

    6.1. OVERVIEW

    6.2. CORD BLOOD

          6.2.1. MARKET VALUE, 2014 TO 2022

          6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022

          6.2.3. MARKET TRENDS AND FORECAST INSIGHTS

    6.3. CORD TISSUE AND CORD BLOOD

          6.3.1. MARKET VALUE, 2014 TO 2022

          6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022

          6.3.3. MARKET TRENDS AND FORECAST INSIGHTS

7. CORD STEM CELL BANKING MARKET, BY SERVICE TYPE

    7.1. OVERVIEW

    7.2. COLLECTION & TRANSPORTATION

    7.3. ANALYSIS

    7.4. PROCESSING 

    7.5. STORAGE

8. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE

    8.1. OVERVIEW

    8.2. UMBILICAL CORD BLOOD

    8.3. BONE MARROW

    8.4. PERIPHERAL BLOOD STEM 

    8.5. MENSTRUAL BLOOD

9. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE

    9.1. OVERVIEW

    9.2. CEREBRAL PALSY

          9.2.1. MARKET VALUE, 2014 TO 2022

          9.2.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.2.3. MARKET TRENDS AND FORECAST INSIGHTS

    9.3. THALASSEMIA

          9.3.1. MARKET VALUE, 2014 TO 2022

          9.3.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.3.3. MARKET TRENDS AND FORECAST INSIGHTS

    9.4. LEUKEMIA 

          9.4.1. MARKET VALUE, 2014 TO 2022

          9.4.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.4.3. MARKET TRENDS AND FORECAST INSIGHTS

    9.5. DIABETES

          9.5.1. MARKET VALUE, 2014 TO 2022

          9.5.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.5.3. MARKET TRENDS AND FORECAST INSIGHTS

    9.6. AUTISM

          9.6.1. MARKET VALUE, 2014 TO 2022

          9.6.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.6.3. MARKET TRENDS AND FORECAST INSIGHTS

    9.7. OTHERS

          9.7.1. MARKET VALUE, 2014 TO 2022

          9.7.2. NUMBER OF UNITS USED, 2014 TO 2022

          9.7.3. MARKET TRENDS AND FORECAST INSIGHTS

10. CORD STEM CELL BANKING MARKET, BY GEOGRAPHY

      10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME)                                                                  (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

              10.1.1. NORTH AMERICA

                        10.1.1.1. U.S.

                        10.1.1.2. CANADA

                        10.1.1.3. MEXICO

              10.1.2. EUROPE

                        10.1.2.1. GERMANY

                        10.1.2.2. FRANCE

                        10.1.2.3. U.K.

                        10.1.2.4. ITALY

                        10.1.2.5. SPAIN

                        10.1.2.6. RUSSIA

                        10.1.2.7. TURKEY

                        10.1.2.8. BELGIUM

                        10.1.2.9. NETHERLANDS

                        10.1.2.10. SWITZERLAND

                        10.1.2.11. REST OF EUROPE

              10.1.3. ASIA-PACIFIC (APAC)

                        10.1.3.1. JAPAN

                        10.1.3.2. CHINA

                        10.1.3.3. SOUTH KOREA

                        10.1.3.4. INDIA

                        10.1.3.5. AUSTRALIA

                        10.1.3.6. SINGAPORE

                        10.1.3.7. THAILAND

                        10.1.3.8. MALAYSIA

                        10.1.3.9. INDONESIA

                        10.1.3.10. PHILIPPINES

                        10.1.3.11. REST OF APAC

              10.1.4. LATIN AMERICA

                        10.1.4.1. BRAZIL

                        10.1.4.2. REST OF LATIN AMERICA

              10.1.5. MIDDLE EAST AND AFRICA

                        10.1.5.1. SOUTH AFRICA

                        10.1.5.2. REST OF MIDDLE EAST AND AFRICA

      10.2.      KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11      CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE

      11.1.      GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

      11.2.      NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

      11.3.      EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

      11.4.      APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS

      11.5.      MERGERS & ACQUISITIONS

      11.6.      NEW PRODUCT DEVELOPMENT & APPROVALS

      11.7.      EXPANSIONS

      11.8.      REGULATORY CHANGES

      11.9.      PATENTS

      11.10.     PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12      CORD STEM CELL BANKING MARKET, COMPANY PROFILES

      12.1       CBR SYSTEMS, INC.

              12.1.1  OVERVIEW

              12.1.2  SWOT ANALYSIS

              12.1.3  PRODUCT PORTFOLIO

              12.1.4  REVENUE ANALYSIS

              12.1.5  ANALYSTS VIEW

      12.2       CORDLIFE

              12.2.1   OVERVIEW

              12.2.2   SWOT ANALYSIS

              12.2.3   PRODUCT PORTFOLIO

              12.2.4   REVENUE ANALYSIS

              12.2.5   ANALYSTS VIEW

      12.3       CRYOCELL

              12.3.1   OVERVIEW

              12.3.2   SWOT ANALYSIS

              12.3.3   PRODUCT PORTFOLIO

              12.3.4   REVENUE ANALYSIS

              12.3.5   ANALYST VIEW

      12.4       CRYO-SAVE AG

              12.4.1   OVERVIEW

              12.4.2   SWOT ANALYSIS

              12.4.3   PRODUCT PORTFOLIO

              12.4.4   REVENUE ANALYSIS

              12.4.5   ANALYSTS VIEW

      12.5       LIFECELL

              12.5.1   OVERVIEW

              12.5.2   SWOT ANALYSIS

              12.5.3   PRODUCT PORTFOLIO

              12.5.4   REVENUE ANALYSIS

              12.5.5   ANALYSTS VIEW

      12.6       STEMCYTE

              12.6.1   OVERVIEW

              12.6.2   SWOT ANALYSIS

              12.6.3   PRODUCT PORTFOLIO

              12.6.4   REVENUE ANALYSIS

              12.6.5   ANALYSTS VIEW

      12.7       SMART CELLS INTERNATIONAL, LTD.

              12.7.1   OVERVIEW

              12.7.2   SWOT ANALYSIS

              12.7.3   PRODUCT PORTFOLIO

              12.7.4   REVENUE ANALYSIS

              12.7.5   ANALYSTS VIEW

      12.8       CRYOVIVA INDIA

              12.8.1   OVERVIEW

              12.8.2   SWOT ANALYSIS

              12.8.3   PRODUCT PORTFOLIO

              12.8.4   REVENUE ANALYSIS

              12.8.5   ANALYSTS VIEW

      12.9       CHINA CORD BLOOD CORPORATION

              12.9.1   OVERVIEW

              12.9.2   SWOT ANALYSIS

              12.9.3   PRODUCT PORTFOLIO

              12.9.4   REVENUE ANALYSIS

              12.9.5   ANALYSTS VIEW

      12.10    CRYOVIDA

              12.10.1   OVERVIEW

              12.10.2   SWOT ANALYSIS

              12.10.3   PRODUCT PORTFOLIO

              12.10.4   REVENUE ANALYSIS

              12.10.5   ANALYSTS VIEW

      12.11    VIACORD

              12.11.1   OVERVIEW

              12.11.2   SWOT ANALYSIS

              12.11.3   PRODUCT PORTFOLIO

              12.11.4   REVENUE ANALYSIS

              12.11.5   ANALYSTS VIEW

13      APPENDIX

      13.1       RELATED REPORTS

      13.2       CUSTOMIZABLE OPTIONS

      13.3       SOURCE SHEET

      13.3       BIBLIOGRAPHY

14      ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Drug Delivery Devices Market – Trends and Forecast to 2022

By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Global Self-Injections Market -Trends and Forecast to 2022

By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), By End-User (Patient, Physicians, Home Care Settings, Others), By Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Sales@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/

Comments are closed.